Helen Fisher

Helen Fisher serves as the Managing Director and CEO of Bio Capital Impact Fund since November 2016 and holds the position of Victorian Branch Chair for AusBiotech, a key organization in Australia's biotechnology sector. In addition to these roles, Helen Fisher is a Non-Executive Director at Calix Limited, where Helen also chairs the Audit and Risk Committee, and previously served as a Non-Executive Director and Chair of the Audit and Risk Committee at Paradigm Biopharmaceuticals. Past experience includes Non-Executive Director roles at BARD1 Life Sciences Ltd and Sienna Cancer Diagnostics. Prior to focusing on the life sciences sector, Helen Fisher was a Partner at Deloitte Australia, specializing in tax until March 2018. Educational qualifications include Bachelor degrees in Laws and Science, along with Master's degrees in Laws (specializing in International Taxation) and Commerce (specializing in Accounting), all obtained from the University of Melbourne and UNSW.